Correlation Between Arcadia Biosciences and Integrated Biopharma

Can any of the company-specific risk be diversified away by investing in both Arcadia Biosciences and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcadia Biosciences and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcadia Biosciences and Integrated Biopharma, you can compare the effects of market volatilities on Arcadia Biosciences and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcadia Biosciences with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcadia Biosciences and Integrated Biopharma.

Diversification Opportunities for Arcadia Biosciences and Integrated Biopharma

-0.43

Correlation Coefficient

Arcadia Biosciences  Integrated Biopharma

Very good diversification

The 3 months correlation between Arcadia and Integrated is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Arcadia Biosciences and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Arcadia Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcadia Biosciences are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Arcadia Biosciences i.e., Arcadia Biosciences and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Arcadia Biosciences and Integrated Biopharma

If you would invest  302.00  in Arcadia Biosciences on September 30, 2024 and sell it today you would earn a total of  309.00  from holding Arcadia Biosciences or generate 102.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	0.79%
Values	Daily Returns

Arcadia Biosciences  vs.  Integrated Biopharma

Arcadia Biosciences

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Integrated Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Arcadia Biosciences and Integrated Biopharma

The main advantage of trading using opposite Arcadia Biosciences and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcadia Biosciences position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.

The idea behind Arcadia Biosciences and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.